Immutep (ASX:IMM) - Webinar Presentation

Company Presentations

by Finance News Network June 23, 2023 05:09 PM

Marc Voigt - Executive Director & CEO - Immutep (ASX:IMM) is a clinical-stage biotechnology company at the forefront of developing novel LAG-3 immunotherapy for cancer and autoimmune diseases. 

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?